According to the press service of the agency, the emergence of new genetic lines of SARS-CoV-2 can change the biological properties of the virus and the clinical manifestations of the infection.
"And also to reduce the effectiveness of therapeutic and prophylactic drugs, including vaccines, developed and tested against earlier variants of the SARS-CoV-2 virus," - said in a press release.
At the same time, the agency noted that to date, the vaccines and drugs developed for the specific prevention of COVID-19 "remain generally effective."
“However, the increase in the rate of occurrence of functionally significant changes in the genome of the virus justifies the need to search for additional solutions,” they added.
As Moscow Mayor Sergei Sobyanin said on June 18, 89.3% of new cases of coronavirus infection had an Indian strain of coronavirus.
According to the director of the Gamaleya Center Alexander Gintsburg, in order to resist the Indian strain of coronavirus, it is necessary to keep high antibody titers and be revaccinated when they decrease.
The developers of the Russian Sputnik V vaccine announced that they plan to present a drug against the Indian strain of infection.